Literature DB >> 13678297

Modeling and docking of the three-dimensional structure of the human melanocortin 4 receptor.

Xiaonan Yang1, Zhuorui Wang, Wei Dong, Lunjiang Ling, Huanming Yang, Runsheng Chen.   

Abstract

A three-dimensional structure of the human melanocortin 4 receptor (hMC4R) is constructed in this study using a computer-aided molecular modeling approach. Human melanocortin 4 receptor is a G Protein-Coupled Receptor (GPCR). We structurally aligned transmembrane helices with bovine rhodopsin transmembrane domains, simulated both intracellular and extracellular loop domains on homologous loop regions in other proteins of known 3D structure and modeled the C terminus on the corresponding part of bovine rhodopsin. Then tandem minimization and dynamics calculations were run to refine the crude structure. The simulative model was tested by docking with a triplet peptide (RFF) ligand. It was found that the ligand is located among transmembrane regions TM3, TM4, TM5, and TM6 of hMC4R. In consistence with mutational and biochemical data, binding site is mainly formed as a hydrophobic and negatively charged pocket. The model constructed here might provide a structural framework for making rational predictions in relevant fields.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678297     DOI: 10.1023/a:1025386022852

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  8 in total

1.  A sucrose-derived scaffold for multimerization of bioactive peptides.

Authors:  Venkataramanarao Rao; Ramesh Alleti; Liping Xu; Narges K Tafreshi; David L Morse; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

2.  Conformational study on cyclic melanocortin ligands and new insight into their binding mode at the MC4 receptor.

Authors:  Paolo Grieco; Diego Brancaccio; Ettore Novellino; Victor J Hruby; Alfonso Carotenuto
Journal:  Eur J Med Chem       Date:  2011-05-23       Impact factor: 6.514

3.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

4.  Synthesis and evaluation of bivalent NDP-alpha-MSH(7) peptide ligands for binding to the human melanocortin receptor 4 (hMC4R).

Authors:  Heather L Handl; Rajesh Sankaranarayanan; Jatinder S Josan; Josef Vagner; Eugene A Mash; Robert J Gillies; Victor J Hruby
Journal:  Bioconjug Chem       Date:  2007-06-26       Impact factor: 4.774

5.  Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

Authors:  Ramesh Alleti; Josef Vagner; Dilani Chathurika Dehigaspitiya; Valerie E Moberg; N G R D Elshan; Narges K Tafreshi; Nabila Brabez; Craig S Weber; Ronald M Lynch; Victor J Hruby; Robert J Gillies; David L Morse; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2013-07-02       Impact factor: 3.641

6.  Contribution of the transmembrane domain 6 of melanocortin-4 receptor to peptide [Pro5, DNal (2')8]-gamma-MSH selectivity.

Authors:  Min Chen; Minying Cai; David McPherson; Victor Hruby; Carroll M Harmon; Yingkui Yang
Journal:  Biochem Pharmacol       Date:  2008-09-30       Impact factor: 5.858

7.  Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.

Authors:  Kathryn L Chapman; Gemma K Kinsella; Alan Cox; Dan Donnelly; John B C Findlay
Journal:  J Mol Biol       Date:  2010-06-19       Impact factor: 5.469

8.  Disturbance of DNA conformation by the binding of testosterone-based platinum drugs via groove-face and intercalative interactions: a molecular dynamics simulation study.

Authors:  Shanshan Cui; Yan Wang; Guangju Chen
Journal:  BMC Struct Biol       Date:  2013-03-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.